Thursday 13 June 2013

Cancer Research UK podcast: June 2013 (Angelina Jolie)

Cancer Research UK podcast: June 2013.

Angelina Jolie’s decision to go public about her genetic risk of breast cancer and double mastectomy. Plus, we take a look at the importance of clinical trials for improving survival for cancer patients. And we’ve got this month’s heroes and zeros. Read a full trasncript here: http://www.cancerresearchuk.org/cancer-info/news/podcast/transcripts/june-2013-podcast-transcript

[podcast]:
Original audio source (94345351-cancerresearchuk-073-cancer-research-uk-podcast.mp3)

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy: A prospective, multicentre cohort study. The lancet oncology, June 2013, Vol. 14(7), p.609-18

Kuehn, T., et al.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70166-9/abstract?rss=yes

The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.

Nipple-sparing mastectomy in patients with a history of reduction mammaplasty or mastoplexy

Nipple-sparing mastectomy in patients with a history of reduction mammaplasty or mastopexy: How safe is it? Plastic and reconstructive surgery, May 2013, Vol. 131(5), p.962-97

Alperovich, M., et al.

http://journals.lww.com/plasreconsurg/Abstract/2013/05000/Nipple_Sparing_Mastectomy_in_Patients_with_a.9.aspx

Nipple-sparing mastectomy has gained popularity, but the question remains of whether it can be offered safely to women with a history of reduction mammaplasty or mastopexy. The authors present their experience with nipple-sparing mastectomy in this patient population.

The role of nipple-sparing mastectomy in breast cancer

The role of nipple-sparing mastectomy in breast cancer: A comprehensive review of the literature. Plastic and reconstructive surgery, May 2013, Vol. 131(5), p.969-984

Mallon, P., et al.

http://journals.lww.com/plasreconsurg/Abstract/2013/05000/The_Role_of_Nipple_Sparing_Mastectomy_in_Breast.11.aspx

The role of nipple-sparing mastectomy for breast cancer is controversial, as there is concern regarding its oncologic safety and complication rate. The authors reviewed the literature to quantify the incidence of occult nipple malignancy in breast cancer, identify the factors influencing occult nipple malignancy, quantify loco-regional recurrence rates, and quantify nipple-sparing mastectomy complication rates.

Screening has not reduced deaths from breast cancer

Screening has not reduced deaths from breast cancer. BMJ 2013; 346: f3780

Wise, J.

http://www.bmj.com/content/346/bmj.f3780.full?rss=1&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A+bmj%252Frecent+%2528Latest+from+BMJ%2529

Mammographic screening has not had any effect, so far, on breast cancer mortality at the population level in England, a new analysis concludes.